Table 1.
Patients’ characteristics.
| Patient ID | Gender | Age | LiPA Genotyping | Liver Stiffness (KPa) * | Risk Factors # | Response Previous Therapy |
|---|---|---|---|---|---|---|
| HCV04 | female | 47 | 1b | 6.0 | Surgery and Cohabitation | Partial responder |
| HCV06 | male | 68 | 1b | 6.5 | Surgery and Cohabitation | Partial responder |
| HCV08 | male | 46 | 1b | 6.0 | Surgery | Relapser |
| HCV09 | male | 62 | 1b/4 | 6.1 | Surgery and Cohabitation | Relapser |
| HCV17 | female | 69 | 1b | 14.0 | Surgery | Naïve |
| HCV19 | male | 45 | 1b | 6.9 | Surgery and Tattoo | Relapser |
| HCV20 | male | 51 | 1b | 22.0 | Surgery | Relapser |
| HCV21 | male | 66 | 1b | 25.0 | Not Available | Partial responder |
* According to Castéra et al. [35], 2005, KPa ≤ 7.1 = F0−F1 (minimal fibrosis), 7.1 < KPa ≤ 9.5 = F2 (moderate fibrosis), 9.5 < KPa ≤ 14.5 = F3 (severe fibrosis), and KPa > 14.5 = F4 (cirrhosis); # Surgery and cohabitation with HCV-antibodies (Ab) positive individuals or tattoo are transmission risks reported by the same patient.